Research / ZM / Fundamental state Inspectable configuration
State dimensions Filing 0001585521-22-000037 General Corporate
Capex intensity 63th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.23% · OPTIONAL · VALID
Operating cash generation 25th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
39.15% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
54.63% · CORE · NOT_ENOUGH_HISTORY
Gross margin 75th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.gross_margin
74.28% · CORE · VALID
Operating margin 63th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.operating_margin
25.94% · CORE · VALID
R&D intensity 75th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
8.85% · OPTIONAL · VALID
SBC intensity 75th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
11.64% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Oct 31, 2021 0/7 normalized Level 3 Jan 31, 2022 6/7 normalized Level 3 Apr 30, 2022 6/7 normalized Level 3 Jul 31, 2022 6/7 normalized Level 3 Oct 31, 2022 6/7 normalized Level 3 Jan 31, 2023 7/7 normalized Level 3 Apr 30, 2023 7/7 normalized Level 3 Jul 31, 2023 7/7 normalized Level 3 Oct 31, 2023 7/7 normalized Level 3 Jan 31, 2024 7/7 normalized Level 3 Apr 30, 2024 7/7 normalized Level 3 Jul 31, 2024 7/7 normalized Level 3 Oct 31, 2024 7/7 normalized Level 3 Jan 31, 2025 7/7 normalized Level 3 Apr 30, 2025 7/7 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 1.88%
Current 3.23%
Delta 1.35% Cash Generation Increased
Previous 37.55%
Current 39.15%
Delta 1.60% Growth Increased
Previous 35.20%
Current 54.63%
Delta 19.43% Margin Increased
Previous 74.21%
Current 74.28%
Delta 0.07% Profitability Decreased
Previous 27.68%
Current 25.94%
Delta -1.74% R And D Intensity Decreased
Previous 9.38%
Current 8.85%
Delta -0.52% Sbc Intensity Increased
Previous 10.93%
Current 11.64%
Delta 0.72% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.